Mannucci E, Monami M, Bardini G, Ognibene A, Rotella C M
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Florence, Italy.
J Endocrinol Invest. 2007 Dec;30(11):925-30. doi: 10.1007/BF03349239.
The adoption of the International Diabetes Federation (IDF) criteria for metabolic syndrome (MS), in comparison with the National Cholesterol Educational Program (NCEP) criteria, produces different changes in estimates of prevalence in diverse populations. Few data are available in Caucasian non-diabetic subjects.
The prevalence of NCEP- and IDF-defined MS was assessed in a sample of 2,945 individuals, aged 55.2+/-11.5 yr, enrolled in a screening program for diabetes. Association of different definitions of MS with glucose intolerance (120-min glucose 7.8 mmol/l after a 75 g-oral glucose load) and hyperuricemia (>0.38 mmol/l) was also assessed.
The prevalence of MS was 16.6% and 29.7% with NCEP and IDF definitions, respectively. The prevalence of NCEP-defined MS was higher than IDF-MS through all age ranges; among those aged >60 yr, the prevalence of IDF-MS reached 52.8% (vs 33.1% for NCEP-MS). Both NCEP- and IDF-MS were associated with glucose intolerance and hyperuricemia. Individuals fulfilling IDF, but not NCEP criteria for MS, showed a prevalence of glucose intolerance (22.7%) significantly (p<0.05) lower than those fulfilling NCEP criteria only (31.6%) or both sets of criteria (31.8%).
In Caucasian subjects without known diabetes, IDF criteria produce a relevant increase in estimates of prevalence of MS, particularly in older subjects, when compared with NCEP criteria. NCEP-MS seems to be more effective than IDF-MS in the identification of glucose intolerant subjects.
与美国国家胆固醇教育计划(NCEP)标准相比,采用国际糖尿病联盟(IDF)代谢综合征(MS)标准会使不同人群的患病率估计值产生不同变化。关于白种非糖尿病受试者的数据较少。
在纳入糖尿病筛查项目的2945名年龄为55.2±11.5岁的个体样本中,评估了NCEP和IDF定义的MS患病率。还评估了MS的不同定义与葡萄糖耐量异常(75克口服葡萄糖负荷后120分钟血糖≥7.8 mmol/l)和高尿酸血症(>0.38 mmol/l)之间的关联。
根据NCEP和IDF定义,MS的患病率分别为16.6%和29.7%。在所有年龄范围内,NCEP定义的MS患病率均高于IDF-MS;在年龄>60岁的人群中,IDF-MS的患病率达到52.8%(而NCEP-MS为33.1%)。NCEP-MS和IDF-MS均与葡萄糖耐量异常和高尿酸血症相关。符合IDF但不符合NCEP MS标准的个体,其葡萄糖耐量异常的患病率(22.7%)显著低于仅符合NCEP标准(31.6%)或同时符合两组标准(31.8%)的个体(p<0.05)。
在无已知糖尿病的白种受试者中,与NCEP标准相比,IDF标准使MS患病率估计值显著增加,尤其是在老年受试者中。在识别葡萄糖耐量异常受试者方面,NCEP-MS似乎比IDF-MS更有效。